First human test: how kidneys handle new drug
NCT ID NCT07217886
Summary
This early-stage study aims to understand how a new drug, S-892216, behaves in the body of people with different levels of kidney function. It will enroll 40 participants, some with healthy kidneys and some with mild to severe kidney problems, including some on dialysis. The main goal is to measure drug levels in the blood and check for safety and side effects to guide future dosing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alliance for Multispecialty Research (AMR)-Knoxville
RECRUITINGKnoxville, Tennessee, 37920, United States
-
Genesis Clinical Research
RECRUITINGTampa, Florida, 33603, United States
-
Global Clinical Professionals (GCP) LLC
RECRUITINGSt. Petersburg, Florida, 33705, United States
-
Orlando Clicinal Research Center
RECRUITINGOrlando, Florida, 32809, United States
Conditions
Explore the condition pages connected to this study.